| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Kyverna Therapeutics, Inc. | Director | Common Stock | 16.6K | $35.1K | $2.11 | May 29, 2025 | Direct |
| Kyverna Therapeutics, Inc. | Director | Stock Option (right to buy) | 65.4K | May 29, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| KYTX | Kyverna Therapeutics, Inc. | May 29, 2025 | 2 | $0 | 4 | Jun 2, 2025 | Director |
| KYTX | Kyverna Therapeutics, Inc. | Oct 21, 2024 | 1 | $0 | 4 | Oct 24, 2024 | Director |
| KYTX | Kyverna Therapeutics, Inc. | Oct 21, 2024 | 0 | $0 | 3 | Oct 24, 2024 | Director |